Metabolic Risk Factors Among People with HIV Contributed to New-Onset Diabetes Seen in the REPRIEVE Cardiovascular Disease Prevention Trial

An analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH). 

Read More